Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8703)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2014 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tanaka K, Masaki Y, Tanaka M, Miyazaki M, Enjoji M, Nakamuta M, Kato M, Nomura M, Inoguchi T, Kotoh K, Takayanagi R. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 2014; 20(10): 2653-2663 [PMID: 24627601 DOI: 10.3748/wjg.v20.i10.2653] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i10/2653.htm |
| Number | Citing Articles |
| 1 |
Ran Li, Zhengqin Ye, Dunmin She, Ping Fang, Guannan Zong, Kerong Hu, Dehong Kong, Wei Xu, Ling Li, Yun Zhou, Keqin Zhang, Ying Xue. Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6. Drug Design, Development and Therapy 2022; : 3557 doi: 10.2147/DDDT.S384884
|
| 2 |
Juan Decara, Sergio Arrabal, Daniel Beiroa, Patricia Rivera, Antonio Vargas, Antonia Serrano, Francisco Javier Pavón, Joan Ballesteros, Carlos Dieguez, Rubén Nogueiras, Fernando Rodríguez de Fonseca, Juan Suárez. Antiobesity efficacy of GLP‐1 receptor agonist liraglutide is associated with peripheral tissue‐specific modulation of lipid metabolic regulators. BioFactors 2016; 42(6): 600 doi: 10.1002/biof.1295
|
| 3 |
D Dutta, S Kalra, M Sharma. Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy. Journal of Postgraduate Medicine 2017; 63(2): 114 doi: 10.4103/0022-3859.191007
|
| 4 |
Ryan P. Ceddia, Sheila Collins. A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure. Clinical Science 2020; 134(5): 473 doi: 10.1042/CS20190579
|
| 5 |
Rodney Rouse, Leshuai Zhang, Katherine Shea, Hongfei Zhou, Lin Xu, Sharron Stewart, Barry Rosenzweig, Jun Zhang, Francisco X. Real. Extended Exenatide Administration Enhances Lipid Metabolism and Exacerbates Pancreatic Injury in Mice on a High Fat, High Carbohydrate Diet. PLoS ONE 2014; 9(10): e109477 doi: 10.1371/journal.pone.0109477
|
| 6 |
Areti Sofogianni, Athanasios Filippidis, Lampros Chrysavgis, Konstantinos Tziomalos, Evangelos Cholongitas. Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. World Journal of Hepatology 2020; 12(8): 493-505 doi: 10.4254/wjh.v12.i8.493
|
| 7 |
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Prevention and Treatment of Atherosclerosis. Handbook of Experimental Pharmacology 2020; 270: 233 doi: 10.1007/164_2020_352
|
| 8 |
Xiankang Fang, Zhiqiang Du, Chunling Duan, Shanshan Zhan, Tian Wang, Mengyu Zhu, Jiajie Shi, Juan Meng, Xianhua Zhang, Maiyun Yang, Yajun Zuo. Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model. Life Sciences 2021; 270: 118966 doi: 10.1016/j.lfs.2020.118966
|
| 9 |
Shan Li, Xiaoman Wang, Jielei Zhang, Jingyi Li, Xiaogang Liu, Yuanyuan Ma, Chao Han, Lixia Zhang, Lili Zheng. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. Brazilian Journal of Medical and Biological Research 2018; 51(8) doi: 10.1590/1414-431x20187299
|
| 10 |
E Pastel, S Joshi, B Knight, N Liversedge, R Ward, K Kos. Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling. Nutrition & Diabetes 2016; 6(12): e235 doi: 10.1038/nutd.2016.44
|
| 11 |
Jinmi Lee, Seok-Woo Hong, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee. Exendin-4 improves ER stress-induced lipid accumulation and regulates lipin-1 signaling in HepG2 cells. Cell Stress and Chaperones 2018; 23(4): 629 doi: 10.1007/s12192-017-0872-z
|
| 12 |
Vittoria Rago, Daniela De Rose, Marta Santoro, Salvatore Panza, Rocco Malivindi, Sebastiano Andò, Rosario D’Agata, Saveria Aquila. Human Sperm Express the Receptor for Glucagon-like Peptide-1 (GLP-1), Which Affects Sperm Function and Metabolism. Endocrinology 2020; 161(4) doi: 10.1210/endocr/bqaa031
|
| 13 |
Yasuhiro Onogi, Ahmed Elagamy Mohamed Mahmoud Khalil, Siegfried Ussar. Identification and characterization of adipose surface epitopes. Biochemical Journal 2020; 477(13): 2509 doi: 10.1042/BCJ20190462
|
| 14 |
Fenghua Li, Yang Yang, Lili Yang, Kai Wang, Xing Zhang, Yunlong Zong, Yixin Ding, Changhong Wang, Li Zhang, Guang Ji. Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stress. Oncotarget 2017; 8(27): 43799 doi: 10.18632/oncotarget.16460
|
| 15 |
Syamala Soumyakrishnan, Rashmi Nagesh, Sujatha Peela, Meenakshisundaram Sreepriya. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 59 doi: 10.1007/978-981-15-5471-1_5
|
| 16 |
N. Shao, X.-Y. Yu, Y.-M. Yu, B.-W. Li, J. Pan, W.-H. Wu, H.-J. Zhang, X.-F. Ma, M. Hao, H.-Y. Kuang. Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. Andrologia 2018; 50(7): e13039 doi: 10.1111/and.13039
|
| 17 |
Amalia Gastaldelli, Kenneth Cusi. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Reports 2019; 1(4): 312 doi: 10.1016/j.jhepr.2019.07.002
|
| 18 |
Bhavin Parekh. A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Research 2015; 4: 119 doi: 10.12688/f1000research.6364.1
|
| 19 |
Emilie Pastel, Laura J. McCulloch, Rebecca Ward, Shivam Joshi, Kim M. Gooding, Angela C. Shore, Katarina Kos. GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction. Clinical Science 2017; 131(5): 343 doi: 10.1042/CS20160803
|
| 20 |
Dinh-Toi Chu, Yang Tao, Kjetil Taskén. OPA1 in Lipid Metabolism: Function of OPA1 in Lipolysis and Thermogenesis of Adipocytes. Hormone and Metabolic Research 2017; 49(04): 276 doi: 10.1055/s-0043-100384
|
| 21 |
Gabriela Svobodová, Martin Horní, Eva Velecká, Iva Boušová. Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review. Archives of Toxicology 2025; 99(1): 1 doi: 10.1007/s00204-024-03889-x
|
| 22 |
J. Decara, P. Rivera, S. Arrabal, A. Vargas, A. Serrano, F. J. Pavón, C. Dieguez, R. Nogueiras, F. Rodríguez de Fonseca, J. Suárez. Cooperative role of the glucagon‐like peptide‐1 receptor and β3‐adrenergic‐mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats. Acta Physiologica 2018; 222(4) doi: 10.1111/apha.13008
|
| 23 |
Li Zhao, Chunfang Zhu, Meng Lu, Chi Chen, Xiaomin Nie, Buatikamu Abudukerimu, Kun Zhang, Zhiyuan Ning, Yi Chen, Jing Cheng, Fangzhen Xia, Ningjian Wang, Michael D Jensen, Yingli Lu. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution. Journal of Endocrinology 2019; 240(2): 271 doi: 10.1530/JOE-18-0374
|
| 24 |
Amalia Gastaldelli, Melania Gaggini, Giuseppe Daniele, Demetrio Ciociaro, Eugenio Cersosimo, Devjit Tripathy, Curtis Triplitt, Peter Fox, Nicolas Musi, Ralph DeFronzo, Patricia Iozzo. Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study. Hepatology 2016; 64(6): 2028 doi: 10.1002/hep.28827
|
| 25 |
İlknur Ozturk Unsal, Murat Calapkulu, Muhammed Erkam Sencar, Basak Cakal, Mustafa Ozbek. Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-04361-x
|